“Pfizer and BioNTech announced today their second agreement with the US government to supply an additional 100 million doses of vaccine,” BioNTech said in a statement.
The cost of the second agreement is estimated at $ 1.95 billion.
Thus, the total volume of vaccine doses supplied to the United States will be increased to 200 million.
Under the agreement, the second batch of vaccines will be delivered in two stages: 70 million doses - by June 30, 2021 and the remaining 30 million - no later than July 31, 2021.
The entire volume of vaccines will be produced in the United States and will make it possible to vaccinate up to 100 million of the country's population.
On December 12, the US approved a vaccine from Pfizer for use in an emergency.
On December 14, the United States received the first COVID-19 vaccine.